REGENERON PHARMACEUTICALS, INC. executive McCourt Marion sold 2,346 shares across two transactions at prices ranging from $850 to $857.39 per share. The transactions left Marion with 12,003 shares, giving investors the disclosed post-sale ownership figure for the EVP Commercial.

Key Highlights

  • McCourt Marion retained 12,003 shares after the transactions.
  • The sales took place between Sep. 2 and Sep. 3, 2026.
  • The transactions covered two sales of Regeneron shares.

REGENERON PHARMACEUTICALS, INC. (NASDAQ: REGN) executive McCourt Marion sold 2,346 shares at prices ranging from $850 to $857.39 per share. The EVP Commercial completed the sales in two transactions spanning Sep. 2 and Sep. 3, 2026.

Two Transactions Cover 2,346 Shares

The transactions were sales of Regeneron shares and carried transaction code S. The prices ranged from $850 to $857.39 per share. Marion’s combined sale amounted to 2,346 shares. McCourt Marion held 12,003 shares after completing the transactions.

Post-Sale Ownership Stands at 12,003 Shares

The disclosed remaining position was 12,003 shares following the sales. That figure represents Marion’s ownership after the two transactions. The filing identifies Marion as EVP Commercial.